Laleman Pharma

Active

Private limited companyfounded 2024active for 2 yearsEsenweg 232, 8600 Diksmuide, BelgiumKBO/BCE: BE 1010.156.713

Summary

Laleman Pharma has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €212,168 and a net result of -€37,832. Its solvency ranks better than 25% of 12,519 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Risk analysisFollow Report Compare

Laleman PharmaActiveChecked score 66/100

Risk analysis Report Compare

History

Laleman Pharma was incorporated on 7 June 2024 as a private limited company.¹ The company has filed annual accounts once, for financial year 2025.²

Acts, filings and financial milestones

All 2Gazette 1Filings 1

2026

08-06

NBB filing Annual accounts filed

financial year 2025 · abbreviated format

2024

11-06

Gazette deed Incorporation

Appointment: Laleman Merel (director) · Registered office clause · Board rule9 facts ▸

Registered office clause, “8600 Diksmuide, Esenweg 232” (deed in Dutch)
Board rule, 1
Director appointment, Laleman Merel (director)
Incorporation, 07-06-2024
Founder, Laleman Merel
Other provision, 23-05-2024
Other provision, “aansprakelijkheid oprichters bij faillissement binnen drie jaar na oprichting bij kennelijk ontoereikend aanvangsvermogen, faillissement binnen drie jaar” (deed in Dutch)
Founding capital, €250,000
Share issue, 100, “vergoeding voor inbrengen” (deed in Dutch)

Gazette deedNBB filing

1 of 1 deed read